Schilling Test

The Schilling Test is one of the methods for diagnosing impaired absorption of vitamin B12 in the human body. This important vitamin is necessary for the normal functioning of the nervous system, hematopoiesis and a number of other processes in the body. A lack of vitamin B12 can lead to various diseases, including pernicious anemia.

To perform the Schilling test, the patient is injected with radioactive vitamin B12, after which urine is collected for analysis 24 hours later. Normally, the vitamin must be absorbed by the body and excreted in the urine. If the absorption of the vitamin is impaired, then its level in the urine will be low.

However, the Schilling test is not the only method for diagnosing impaired absorption of vitamin B12. There are now more accurate and reliable methods, such as intrinsic factor antibody tests and homocysteine ​​tests.

Despite this, the Schilling test can still be useful in diagnosing vitamin B12 malabsorption, especially in cases where other diagnostic methods are not available or do not provide a clear result. In addition, the Schilling test can be used to evaluate the effectiveness of treatment for disorders of vitamin B12 absorption.

In conclusion, the Schilling test is an important method for diagnosing vitamin B12 malabsorption. However, to obtain more accurate results, it is recommended to use other diagnostic methods. If you suspect a vitamin B12 absorption disorder, contact your doctor for advice and to order appropriate tests.

The Schilling test is a method used to determine a person's ability to absorb vitamin B12. This method is also known as the "Schilling test". The Schilling test was developed in 1925 by German physician and biochemist Carl Schilling, who was one of the first researchers to study vitamin B12 and its role in the body.

The method involves a person ingesting radioactive vitamin B12 and then collecting urine after 24 hours. If a person has a normal ability to absorb vitamin B12, then by this time he should have excreted at least 10 percent of the originally taken dose. However, if a person has a vitamin B12 deficiency or other absorption problems, they may excrete less.

The Schilling test is an important diagnostic test for identifying vitamin B12 deficiency in the body and assessing a person's ability to absorb this vitamin. It can also be used to determine the effectiveness of treatment for vitamin B12 deficiency in patients.

The Schilling test is a test that measures the absorption of B-complex vitamins, including vitamin B12. This is an important test to evaluate the functioning of the nervous system, liver and gastrointestinal tract.

Normally, the result of a urine test shows a high level of antibodies against vitamin B12, which means that the person can safely absorb this vitamin. However, in people with insufficient levels of abrecin globulin, absorption of the vitamin in the stomach and intestines is reduced and, accordingly, antibodies against it are reduced. Namely, these antibodies determine the presence of disorders on the part of these organs and systems.